Telomerase inhibition is an effective therapeutic strategy in<i>TERT</i>promoter-mutant glioblastoma models with low tumor volume
Elisa Aquilanti(Broad Institute), Matthew Meyerson(Broad Institute)
Cited by 30
Related Papers
Characterizing the cancer genome in lung adenocarcinoma
|Nature|2007|1.1k
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
|PLoS Medicine|2005|683
Targeted genomic rearrangements using CRISPR/Cas technology
|Nature Communications|2014|317
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells
|Nature Communications|2018|254